Innovent Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:1801 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
05 Dec 24	SellHK$30,150,656	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	803,621	HK$37.52
30 Oct 24	SellHK$308,323,657	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	8,668,935	HK$35.57
29 Oct 24	BuyHK$173,805,835	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	4,592,813	HK$37.84
10 Oct 24	SellHK$533,963,168	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	10,891,140	HK$49.03
08 Oct 24	BuyHK$548,077,815	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	11,412,177	HK$48.03
02 Oct 24	SellHK$81,170,776	De-Chao Yu	Individual	1,750,000	HK$46.72
30 Sep 24	SellHK$70,584,004	De-Chao Yu	Individual	1,500,000	HK$47.37
27 Sep 24	SellHK$33,657,461	Hao Xi Ede	Individual	736,500	HK$45.70
26 Sep 24	SellHK$3,651,200	Hao Xi Ede	Individual	81,500	HK$44.80
11 Sep 24	BuyHK$86,095	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	2,000	HK$43.05
11 Sep 24	BuyHK$86,095	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	Company	2,000	HK$43.05
11 Sep 24	SellHK$1,743,432	JP Morgan Asset Management	Company	40,500	HK$43.05
11 Sep 24	SellHK$666,472,087	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	15,482,177	HK$43.05
10 Sep 24	BuyHK$448,670,085	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	10,624,087	HK$42.23
10 Jul 24	SellHK$99,421,894	Capital Research and Management Company	Company	2,755,000	HK$36.09
03 May 24	SellHK$36,587,668	De-Chao Yu	Individual	906,250	HK$40.37
02 Feb 24	BuyHK$60,788,476	Capital Research and Management Company	Company	1,869,776	HK$32.51
12 Jan 24	BuyHK$51,892,586	Capital Research and Management Company	Company	1,292,500	HK$40.15
05 Jan 24	SellHK$133,714,368	Capital Research and Management Company	Company	3,456,000	HK$38.69

Insider Trading Volume

Insider Buying: 1801 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1801?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	10,614,500	0.648%
VC/PE Firms	89,475,350	5.46%
Individual Insiders	110,666,823	6.76%
Institutions	687,529,020	42%
General Public	739,624,153	45.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 45.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.92%	Capital Research and Management Company	113,425,003	HK$4.0b	-0.65%	0.02%
6.53%	De-Chao Yu	107,003,778	HK$3.8b	-1.61%	no data
5.46%	SDIC Innovation Investment Management Co., Ltd.	89,475,350	HK$3.1b	0%	25.15%
3.58%	The Vanguard Group, Inc.	58,590,227	HK$2.1b	0.48%	no data
2.74%	BlackRock, Inc.	44,918,246	HK$1.6b	5.6%	no data
2.22%	GF Fund Management Co., Ltd.	36,440,000	HK$1.3b	0%	0.34%
2.03%	Fidelity International Ltd	33,326,440	HK$1.2b	-1.1%	0.06%
1.98%	Norges Bank Investment Management	32,441,094	HK$1.1b	0%	0.01%
1.82%	Temasek Holdings (Private) Limited	29,751,000	HK$1.0b	136%	0.12%
1.52%	Citigroup Inc.,Banking and Securities Investments	24,932,063	HK$877.6m	0%	0.08%
1.46%	Bosera Asset Management Co., Ltd.	23,965,000	HK$843.6m	0%	0.48%
1.43%	Harvest Fund Management Co. Ltd.	23,397,288	HK$823.6m	0%	0.23%
1.14%	E Fund Management Co., Ltd.	18,603,000	HK$654.8m	0%	0.1%
0.82%	FMR LLC	13,398,681	HK$471.6m	0%	no data
0.76%	Schroder Investment Management Limited	12,410,500	HK$436.8m	1.4%	0.04%
0.73%	China Asset Management Co. Ltd.	11,944,751	HK$420.5m	-0.96%	0.06%
0.6%	Polar Capital Holdings Plc	9,834,562	HK$346.2m	2.73%	0.16%
0.59%	Schroder Investment Management North America Inc.	9,651,500	HK$339.7m	-0.01%	0.14%
0.51%	ICBC Credit Suisse Asset Management Co., Ltd.	8,343,974	HK$293.7m	0%	0.2%
0.48%	Invesco Ltd.	7,802,000	HK$274.6m	1.36%	0.01%
0.45%	Schroder Investment Management (Hong Kong) Ltd.	7,410,000	HK$260.8m	0%	0.2%
0.41%	Fullerton (Private) Limited	6,673,500	HK$234.9m	0%	no data
0.39%	Bank of China Investment Management Co., Ltd.	6,356,000	HK$223.7m	0%	0.65%
0.36%	UBS Asset Management AG	5,833,209	HK$205.3m	28.7%	no data
0.35%	Geode Capital Management, LLC	5,729,863	HK$201.7m	1.88%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 03:58
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Innovent Biologics, Inc. is covered by 53 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Linda Lu	BOCI Research Ltd.
Wai Chak Yuen	BOCI Research Ltd.
Bo Li	BofA Global Research